Skip to content

Diastat Anti-Thyroid Peroxidase Kit

by Shield Diagnostics, Ltd.

510(k) K951487

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK951487 Date30 Jun 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JZO
Device Class
Class II
Regulation
21 CFR Part 866.5870
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Diastat Anti-Thyroid Peroxidase Kit is an in vitro diagnostic device used for the qualitative detection of antibodies to thyroid peroxidase (TPO) in human serum or plasma. It functions as a test system for identifying autoimmune thyroid disease by measuring anti-TPO autoantibodies, which are associated with conditions such as Hashimoto’s thyroiditis and Graves’ disease.

This kit is intended for laboratory use and is supplied as a single-use diagnostic test. It is classified as a Class II device under FDA regulations (21 CFR 866.5870) and has received FDA 510(k) clearance (K951487) as substantially equivalent to a predicate device. The kit includes all necessary reagents and components for performing the test, with no specific sterility or MRI safety requirements noted. Storage conditions are not detailed in the provided data.

Other devices from Shield Diagnostics, Ltd.

See all devices from Shield Diagnostics, Ltd. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Diastat Anti-Thyroid Peroxidase Kit used for in clinical practice?

    The Diastat Anti-Thyroid Peroxidase Kit is designed for the qualitative detection of antibodies to thyroid peroxidase (anti-TPO) in human serum or plasma. These antibodies are linked to autoimmune thyroid diseases like Hashimoto’s thyroiditis and Graves’ disease, so the test helps identify patients who may have these conditions. It is intended strictly for laboratory use to screen for autoimmune thyroid disorders.

  • Is this kit single-use, or can it be reused across multiple patients?

    The Diastat Anti-Thyroid Peroxidase Kit is explicitly labeled as a single-use diagnostic test. This means each kit is intended for one test procedure only and should not be reused for multiple patients or samples to ensure accuracy and prevent contamination.

  • What storage conditions should be followed for this kit, and are there any special handling requirements?

    The provided data does not specify storage conditions for the Diastat Anti-Thyroid Peroxidase Kit. However, as with most diagnostic reagents, it is generally recommended to store the kit in a cool, dry place away from direct sunlight and extreme temperatures. Always refer to the manufacturer’s instructions included with the kit for precise storage guidance.

  • How was the regulatory pathway for this device determined, and what does the product code (JZO) indicate?

    The Diastat Anti-Thyroid Peroxidase Kit was cleared through the FDA’s 510(k) process, specifically under the Traditional pathway, and was deemed substantially equivalent to a predicate device. The product code JZO categorizes this device under the FDA’s classification system for in vitro diagnostic tests, particularly those related to immunology. This code reflects its use in detecting thyroid autoantibodies, aligning with the Immunology advisory committee (IM) that reviewed it.